|
 |
| |
|
ÀÚÀÌÄ«µð¾ÆÄ¸½¶150mg(¼¼¸®Æ¼´Õ) Zykadia Cap. 150mg
|
Àü¹®ÀǾàǰ | ±Þ¿© | Èñ±ÍÀǾàǰ | ºÐ¾÷¿¹¿ÜÀǾàǰ(45)
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| Èò»ö ³»Áö °ÅÀÇ Èò»öÀÇ °¡·ç¸¦ ÇÔÀ¯ÇÑ »óºÎ ÆÄ¶û»ö ÇϺΠÈò»öÀÇ ºÒÅõ¸í °æÁú ĸ½¶ |
|
|
|
|
|
Á¦Á¶È¸»ç |
Çѱ¹³ë¹ÙƼ½º(ÁÖ)
|
ÆÇ¸Åȸ»ç |
Çѱ¹³ë¹ÙƼ½º(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2015.01.12)
|
BIT ¾àÈ¿ºÐ·ù |
´Ü¹éÁú ÀλêÈÈ¿¼Ò ¾ïÁ¦Á¦(Protein kinase inhibitors)
|
º¹ÁöºÎºÐ·ù |
421[Ç׾ǼºÁ¾¾çÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
653602530 \31,271 ¿ø/1ĸ½¶(2018.11.01)(ÇöÀç¾à°¡)\36,362 ¿ø/1ĸ½¶(2017.07.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
ceritinib / L01ED02 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
ÀÌ»êÈÆ¼ÅºE171,
Àεð°íÄ«¸£¹Î,
ÀúġȯÈ÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
ÀüºÐ±Û¸®Äݻ곪Ʈ·ý,
Á©¶óƾ,
ÄÝ·ÎÀ̵强ÀÌ»êȱԼÒ
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-02-24 |
|
|
|
|
| |
|
|
|